Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold

Author(s): Guanglong Bao, Baoquan Du, Yuxiu Ma, Meng Zhao, Ping Gong, Xin Zhai

Journal Name: Medicinal Chemistry

Volume 12 , Issue 5 , 2016

Become EABM
Become Reviewer


Two series of novel benzothiazole derivatives conjugated with semicarbazone scaffold were designed and synthesized through a structure-based molecular hybridization strategy. All the target compounds were evaluated for their cytotoxicity in vitro against three cancer cell lines (HT-29, MKN-45 and H460) by standard MTT assay. The pharmacological results indicated that seven compounds (17h-n) exhibited comparable or even better antiproliferative activity in comparison with reference drugs Sorafenib and PAC-1. Particularly, compound 17i displayed remarkable cytotoxicity against tested three cancer cell lines with IC50 values of 0.84, 0.06 and 0.52 µM, which were 4.3-, 36.6-, 4.2-folds more potent than Sorafenib and 1.2-, 13.7-, 6.9-times more active than PAC-1, respectively.

Keywords: Benzothiazole, semicarbazone, synthesis, antiproliferative activity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 23 June, 2016
Page: [489 - 498]
Pages: 10
DOI: 10.2174/1573406412666160107113343
Price: $65

Article Metrics

PDF: 38